Table 2. Treatment regimens for the TREXA study.
Group | Subjects n | Regular therapy | Exacerbation therapy |
1 | 71 | BDP 50 μg twice a day | BDP 100 μg/β2-rescue |
2 | 72 | Placebo | BDP 100 μg/β2-rescue |
3 | 71 | BDP 50 μg twice a day | Placebo/β2-rescue |
4 | 74 | Placebo | Placebo/β2-rescue |
TREXA: TReating Children to Prevent Exacerbations of Asthma; BDP: beclomethasone diproprionate.